Pancreatic Cancer Research

ResearcherTUM KlinikumActive in the last 2 years

Marc Eric Martignoni

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5030352084, A5083442263. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
86
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 13

  1. Heterogeneity in the management of patients with locally advanced pancreatic cancer: current surgeons' perspective and lessons for the future. First author DOI 10.1007/s13304-026-02651-5↗
  2. Extent of N-glycosylation of the metalloproteinase inhibitor and cytokine TIMP-1 determines pancreatic cancer cell proliferation and survival via CD63. Co-author DOI 10.1016/j.jbc.2025.110211↗
  3. A retrospective, multicentric, nationwide analysis of the impact of splenectomy on survival of pancreatic cancer patients. Co-author DOI 10.1007/s00423-024-03570-y↗
  4. Arterial Resection for Pancreatic Cancer: Feasibility and Current Standing in a High-Volume Center. Co-author DOI 10.1097/as9.0000000000000302↗
  5. [Nutritional therapies for patients with pancreatic cancer]. Last author DOI 10.1007/s15006-020-4495-4↗
  6. Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology. Co-author DOI 10.1172/jci.insight.137809↗
  7. Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and… Co-author DOI 10.1186/s12885-018-4055-9↗
  8. 3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer. Co-author DOI 10.1016/j.ejca.2017.03.022↗
  9. IL-4 mRNA Is Downregulated in the Liver of Pancreatic Cancer Patients Suffering from Cachexia. Last author DOI 10.1080/01635581.2017.1247885↗
  10. Genetic analysis of circulating tumor cells in pancreatic cancer patients: A pilot study. Co-author DOI 10.1016/j.ygeno.2015.02.003↗
  11. Cachexia and pancreatic cancer: are there treatment options? Last author DOI 10.3748/wjg.v20.i28.9361↗
  12. Cachexia in patients with chronic pancreatitis and pancreatic cancer: impact on survival and outcome. Last author DOI 10.1080/01635581.2013.804580↗
  13. Real-imaging cDNA-AFLP transcript profiling of pancreatic cancer patients: Egr-1 as a potential key regulator of muscle cachexia. Co-author DOI 10.1186/1471-2407-12-265↗

Closest collaborators

The 25 strongest of 86 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Helmut Friess · 5 shared papers, 2018–2026 · strength 0.89
  2. Guralp Onur Ceyhan · 4 shared papers, 2020–2026 · strength 0.69
  3. Ilaria Pergolini · 3 shared papers, 2023–2026 · strength 0.62
  4. Alexander Novotny · 3 shared papers, 2023–2026 · strength 0.62
  5. İhsan Ekin Demir · 3 shared papers, 2023–2026 · strength 0.62
  6. Stephan Schorn · 3 shared papers, 2020–2024 · strength 0.49
  7. Helmut Frieß · 4 shared papers, 2013–2025 · strength 0.42
  8. Olga Prokopchuk · 3 shared papers, 2017–2025 · strength 0.38
  9. Mert Erkan · 1 shared paper, 2026 · strength 0.32
  10. Ugo Boggi · 1 shared paper, 2026 · strength 0.32
  11. Achim Krüger · 2 shared papers, 2018–2025 · strength 0.31
  12. Maximilian Kießler · 2 shared papers, 2023–2024 · strength 0.30
  13. Rüdiger Göß · 2 shared papers, 2023–2024 · strength 0.30
  14. Okan Safak · 2 shared papers, 2023–2024 · strength 0.30
  15. Jeannine Bachmann · 5 shared papers, 2012–2017 · strength 0.28
  16. Julian Frädrich · 1 shared paper, 2025 · strength 0.23
  17. Daniel Häußler · 1 shared paper, 2025 · strength 0.23
  18. Werner Hartwig · 2 shared papers, 2017–2024 · strength 0.19
  19. Jens Werner · 2 shared papers, 2017–2024 · strength 0.19
  20. Lei Ren · 1 shared paper, 2023 · strength 0.17
  21. Ulrich Nitsche · 2 shared papers, 2017–2018 · strength 0.16
  22. Tim R. Glowka · 1 shared paper, 2024 · strength 0.14
  23. Tobias Keck · 1 shared paper, 2024 · strength 0.14
  24. Michael B. Ghadimi · 1 shared paper, 2024 · strength 0.14
  25. Soeren Torge Mees · 1 shared paper, 2024 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.